Cargando…
A Designed Zinc-finger Transcriptional Repressor of Phospholamban Improves Function of the Failing Heart
Selective inhibition of disease-related proteins underpins the majority of successful drug–target interactions. However, development of effective antagonists is often hampered by targets that are not druggable using conventional approaches. Here, we apply engineered zinc-finger protein transcription...
Autores principales: | Zhang, H Steve, Liu, Dingang, Huang, Yan, Schmidt, Stefan, Hickey, Reed, Guschin, Dmitry, Su, Haili, Jovin, Ion S, Kunis, Mike, Hinkley, Sarah, Liang, Yuxin, Hinh, Linda, Spratt, S Kaye, Case, Casey C, Rebar, Edward J, Ehrlich, Barbara, Gregory, Philip D, Giordano, Frank J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412484/ https://www.ncbi.nlm.nih.gov/pubmed/22828502 http://dx.doi.org/10.1038/mt.2012.80 |
Ejemplares similares
-
Phospholamban Is Downregulated by pVHL-Mediated Degradation through Oxidative Stress in Failing Heart
por: Yokoe, Shunichi, et al.
Publicado: (2017) -
KRAB-containing zinc-finger repressor proteins
por: Urrutia, Raul
Publicado: (2003) -
Negative Adrenergic Feedback Specific to Phospholamban
por: Hasenfuss, Gerd, et al.
Publicado: (2017) -
Prevalence and cardiac phenotype of patients with a phospholamban mutation
por: Hof, I. E., et al.
Publicado: (2018) -
Immunoelectron microscopical localization of phospholamban in adult canine ventricular muscle
Publicado: (1987)